메뉴 건너뛰기




Volumn 34, Issue 1, 2003, Pages 41-47

Cell cycle regulators in multiple myeloma: Prognostic implications of p53 nuclear accumulation

Author keywords

Cell cycle; Immunohistochemistry; Multiple myeloma; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN E; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

EID: 0037255806     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.6     Document Type: Article
Times cited : (19)

References (43)
  • 1
    • 0031985198 scopus 로고    scopus 로고
    • Multiple myeloma: Increasing evidence for a multistep transformation process
    • Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3-21, 1998
    • (1998) Blood , vol.91 , pp. 3-21
    • Hallek, M.1    Bergsagel, P.L.2    Anderson, K.C.3
  • 2
    • 0027359827 scopus 로고
    • WAF 1, a potential mediator of p53 tumor suppression
    • El-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
    • (1993) Cell , vol.75 , pp. 817-825
    • El-Deiry, W.S.1    Tokino, T.2    Velculescu, V.E.3
  • 3
    • 0027244853 scopus 로고    scopus 로고
    • The p53-mdm-2 autoregulatory feedback loop
    • Wu X, Bayle JH, Olson D, et al: The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-1132, 199 3
    • Genes Dev , vol.7 , pp. 1126-1132
    • Wu, X.1    Bayle, J.H.2    Olson, D.3
  • 4
    • 0026437723 scopus 로고
    • p53 and RAS gene mutations in multiple myeloma
    • Portier M, Moles JP, Mazars GR, et al: p53 and RAS gene mutations in multiple myeloma. Oncogene 7:2539-2543, 1992
    • (1992) Oncogene , vol.7 , pp. 2539-2543
    • Portier, M.1    Moles, J.P.2    Mazars, G.R.3
  • 5
    • 0027505575 scopus 로고
    • p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
    • Neri A, Baldini L, Trecca D, et al: p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81:128-135, 1993
    • (1993) Blood , vol.81 , pp. 128-135
    • Neri, A.1    Baldini, L.2    Trecca, D.3
  • 6
    • 0029153427 scopus 로고
    • N-ras and p 53 gene mutations are very rare events in multiple myeloma
    • Yasuga Y, Hirosawa S, Yamamoto K, et al: N-ras and p53 gene mutations are very rare events in multiple myeloma. Int J Hematol 62:91-97, 1995
    • (1995) Int J Hematol , vol.62 , pp. 91-97
    • Yasuga, Y.1    Hirosawa, S.2    Yamamoto, K.3
  • 7
    • 0031043342 scopus 로고    scopus 로고
    • p53 gene mutations in multiple myeloma
    • Owen RG, Davis SA, Randerson J, et al: p53 gene mutations in multiple myeloma. Mol Pathol 50:18-20, 1997
    • (1997) Mol Pathol , vol.50 , pp. 18-20
    • Owen, R.G.1    Davis, S.A.2    Randerson, J.3
  • 8
    • 0032147210 scopus 로고    scopus 로고
    • Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
    • Drach J, Ackermann J, Fritz E, et al: Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood 92:802-809, 1998
    • (1998) Blood , vol.92 , pp. 802-809
    • Drach, J.1    Ackermann, J.2    Fritz, E.3
  • 9
    • 0030612728 scopus 로고    scopus 로고
    • INK4A are preferentially expressed in immature and mature myeloma cells, respectively
    • INK4A are preferentially expressed in immature and mature myeloma cells, respectively. Brit J Haematol 99:131-138, 1997
    • (1997) Brit J Haematol , vol.99 , pp. 131-138
    • Kawano, M.M.1    Mahmoud, M.S.2    Ishikawa, H.3
  • 10
    • 0034212785 scopus 로고    scopus 로고
    • Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p 21, and apoptosis
    • Park WH, Seol JG, Kim ES, et al: Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60:3065-3071, 2000
    • (2000) Cancer Res , vol.60 , pp. 3065-3071
    • Park, W.H.1    Seol, J.G.2    Kim, E.S.3
  • 11
    • 0030921866 scopus 로고    scopus 로고
    • MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells
    • Teoh G, Urashima M, Ogata A, et al: MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood 90:1982-1992, 1997
    • (1997) Blood , vol.90 , pp. 1982-1992
    • Teoh, G.1    Urashima, M.2    Ogata, A.3
  • 12
    • 0031840937 scopus 로고    scopus 로고
    • waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin D 1 immunoreactivity
    • waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin D1 immunoreactivity Mod Pathol 11:642-647, 1998
    • (1998) Mod Pathol , vol.11 , pp. 642-647
    • Lai, R.1    Medeiros, L.J.2    Wilson, C.S.3
  • 13
    • 0029849620 scopus 로고    scopus 로고
    • Cancer cell cycles
    • Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996
    • (1996) Science , vol.274 , pp. 1672-1677
    • Sherr, C.J.1
  • 14
    • 0028986932 scopus 로고
    • kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
    • kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55:1211-1214, 1995
    • (1995) Cancer Res , vol.55 , pp. 1211-1214
    • Ponce-Castaneda, M.V.1    Lee, M.H.2    Latres, E.3
  • 16
    • 0032923368 scopus 로고    scopus 로고
    • Cyclin E in human cancers
    • Donnellan R, Chetty R: Cyclin E in human cancers. FASEBJ 13:773-780, 1999
    • (1999) FASEBJ , vol.13 , pp. 773-780
    • Donnellan, R.1    Chetty, R.2
  • 17
    • 0032147113 scopus 로고    scopus 로고
    • Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: Prognostic implications
    • Erlanson M, Portin C, Linderholm B, et al: Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: Prognostic implications. Blood 92:770-777, 1998
    • (1998) Blood , vol.92 , pp. 770-777
    • Erlanson, M.1    Portin, C.2    Linderholm, B.3
  • 19
    • 0033838792 scopus 로고    scopus 로고
    • Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)
    • Pruneri G, Fabris S, Baldini L, et al: Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol 156:1505-1513, 2000
    • (2000) Am J Pathol , vol.156 , pp. 1505-1513
    • Pruneri, G.1    Fabris, S.2    Baldini, L.3
  • 20
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma
    • Durie BGM, Salmon S: A clinical staging system for multiple myeloma. Cancer 36:842-854, 1975
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.M.1    Salmon, S.2
  • 21
    • 0023125752 scopus 로고
    • Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases
    • Bartl R, Frisch B, Fateh-Moghadam A, et al: Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases. Am J Clin Pathol 87:342-355, 1987
    • (1987) Am J Clin Pathol , vol.87 , pp. 342-355
    • Bartl, R.1    Frisch, B.2    Fateh-Moghadam, A.3
  • 22
    • 0030887695 scopus 로고    scopus 로고
    • Standard therapy - Versus autologous transplantation in multiple myeloma
    • Attal M, Harousseau JL: Standard therapy - versus autologous transplantation in multiple myeloma. Hematol Oncol Clin North Am 11:133-146, 1997
    • (1997) Hematol Oncol Clin North Am , vol.11 , pp. 133-146
    • Attal, M.1    Harousseau, J.L.2
  • 23
    • 0030805232 scopus 로고    scopus 로고
    • MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation
    • Pruneri G, Pignataro L, Carboni N, et al: MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation. Mod Pathol 10:785-792, 1997
    • (1997) Mod Pathol , vol.10 , pp. 785-792
    • Pruneri, G.1    Pignataro, L.2    Carboni, N.3
  • 25
    • 12944283204 scopus 로고    scopus 로고
    • Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
    • Chiarle R, Budel LM, Skolnik J, et al: Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95:619-626, 2000
    • (2000) Blood , vol.95 , pp. 619-626
    • Chiarle, R.1    Budel, L.M.2    Skolnik, J.3
  • 26
    • 0035751937 scopus 로고    scopus 로고
    • Assessing TP53 status in human tumours to evaluate clinical outcome
    • Soussi T, Beroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233-240, 2001
    • (2001) Nat Rev Cancer , vol.1 , pp. 233-240
    • Soussi, T.1    Beroud, C.2
  • 27
    • 0028236846 scopus 로고
    • Induction of WAF1/CIP1 by a p53-independent pathway
    • Michieli P, Chedid M, Lin D, et al: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395, 1994
    • (1994) Cancer Res , vol.54 , pp. 3391-3395
    • Michieli, P.1    Chedid, M.2    Lin, D.3
  • 28
    • 0036247821 scopus 로고    scopus 로고
    • p53-Mdm2 - The affair that never ends
    • Alarcon-Vargas D, Ronai Z: p53-Mdm2 - the affair that never ends. Carcinogenesis 23:541-547, 2002
    • (2002) Carcinogenesis , vol.23 , pp. 541-547
    • Alarcon-Vargas, D.1    Ronai, Z.2
  • 29
    • 0032417695 scopus 로고    scopus 로고
    • Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
    • Jones SN, Hancock AR, Vogel H, et al: Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A 95:15608-15612, 1998
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 15608-15612
    • Jones, S.N.1    Hancock, A.R.2    Vogel, H.3
  • 30
    • 0026649648 scopus 로고
    • The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
    • Momand J, Zambetti GP, Olson DC, et al: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245, 1992
    • (1992) Cell , vol.69 , pp. 1237-1245
    • Momand, J.1    Zambetti, G.P.2    Olson, D.C.3
  • 31
    • 0027325132 scopus 로고
    • Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
    • Oliner JD, Pietenpol J, Thiagalingam S, et al: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860, 1993
    • (1993) Nature , vol.362 , pp. 857-860
    • Oliner, J.D.1    Pietenpol, J.2    Thiagalingam, S.3
  • 32
  • 33
    • 0027368879 scopus 로고
    • The human MDM-2 oncogene is overexpressed in leukemias
    • Bueso-Ramos CE, Yang Y, deleon E, et al: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617-2623, 1993
    • (1993) Blood , vol.82 , pp. 2617-2623
    • Bueso-Ramos, C.E.1    Yang, Y.2    Deleon, E.3
  • 34
    • 0027337423 scopus 로고
    • Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes
    • Preudhomme C, Quesnel B, Vachee A, et al: Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia 7:1291-1293, 1993
    • (1993) Leukemia , vol.7 , pp. 1291-1293
    • Preudhomme, C.1    Quesnel, B.2    Vachee, A.3
  • 35
    • 0028286492 scopus 로고
    • Lack of MDM2 amplification in human leukaemia
    • Ridge SA, Dyer M, Greaves MF, et al: Lack of MDM2 amplification in human leukaemia. Brit J Haematol 86:407-409, 1994
    • (1994) Brit J Haematol , vol.86 , pp. 407-409
    • Ridge, S.A.1    Dyer, M.2    Greaves, M.F.3
  • 36
    • 0030032584 scopus 로고    scopus 로고
    • mdm-2 oncogene expression in non-Hodgkin's lymphomas
    • Kawamata N, Miller C, Levy V, et al: mdm-2 oncogene expression in non-Hodgkin's lymphomas. Diagn Mol Pathol 5:33-38, 1996
    • (1996) Diagn Mol Pathol , vol.5 , pp. 33-38
    • Kawamata, N.1    Miller, C.2    Levy, V.3
  • 37
    • 0032568334 scopus 로고    scopus 로고
    • Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells
    • Capoulade C, Bressac-de Paillerets B, Lefrere I, et al: Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Oncogene 16: 1603-1610, 1998
    • (1998) Oncogene , vol.16 , pp. 1603-1610
    • Capoulade, C.1    Bressac-de Paillerets, B.2    Lefrere, I.3
  • 38
    • 0031939875 scopus 로고    scopus 로고
    • Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage
    • Chen L, Agrawal S, Zhou W, et al: Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A 95:195-200, 1998
    • (1998) Proc Natl Acad Sci U S A , vol.95 , pp. 195-200
    • Chen, L.1    Agrawal, S.2    Zhou, W.3
  • 39
    • 0035865516 scopus 로고    scopus 로고
    • Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides
    • Capoulade C, Mir LM, Carlier K, et al: Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood 97:1043-1049, 2001
    • (2001) Blood , vol.97 , pp. 1043-1049
    • Capoulade, C.1    Mir, L.M.2    Carlier, K.3
  • 40
    • 0035204480 scopus 로고    scopus 로고
    • Expression of cyclin E and cyclin D1 in non-small cell lung cancers
    • Yamanouchi H, Furihata M, Fujita J, et al: Expression of cyclin E and cyclin D1 in non-small cell lung cancers. Lung Cancer 31:3-8, 2001
    • (2001) Lung Cancer , vol.31 , pp. 3-8
    • Yamanouchi, H.1    Furihata, M.2    Fujita, J.3
  • 41
    • 0035122539 scopus 로고    scopus 로고
    • Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications
    • Donnellan R, Kleinschmidt I, Chetty R: Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications. HUM PATHOL 32:89-94, 2001
    • (2001) Hum Pathol , vol.32 , pp. 89-94
    • Donnellan, R.1    Kleinschmidt, I.2    Chetty, R.3
  • 43
    • 0027283604 scopus 로고
    • Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
    • Lotem J, Sachs L: Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82:1092-1096, 1993
    • (1993) Blood , vol.82 , pp. 1092-1096
    • Lotem, J.1    Sachs, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.